Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $32.18 in the prior trading day, Collegium Pharmaceutical Inc (NASDAQ: COLL) closed at $31.41, down -2.39%. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 0.72 million shares were traded. COLL stock price reached its highest trading level at $32.18 during the session, while it also had its lowest trading level at $30.715.
Ratios:
Our goal is to gain a better understanding of COLL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.26. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.97. In the meantime, Its Debt-to-Equity ratio is 4.24 whereas as Long-Term Debt/Eq ratio is at 3.96.
On June 07, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $41 to $44.
Piper Sandler Downgraded its Overweight to Neutral on May 10, 2024, while the target price for the stock was maintained at $39.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 13 ’24 when Smith Thomas B sold 9,593 shares for $36.62 per share. The transaction valued at 351,320 led to the insider holds 53,816 shares of the business.
Smith Thomas B bought 373 shares of COLL for $13,794 on Sep 13 ’24. On Sep 13 ’24, another insider, Smith Thomas B, who serves as the Officer of the company, bought 9,220 shares for $36.61 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COLL now has a Market Capitalization of 1037811520 and an Enterprise Value of 1742417920. As of this moment, Collegium’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.55, and their Forward P/E ratio for the next fiscal year is 4.78. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 24.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.69 while its Price-to-Book (P/B) ratio in mrq is 4.32. Its current Enterprise Value per Revenue stands at 2.908 whereas that against EBITDA is 4.763.
Stock Price History:
Over the past 52 weeks, COLL has reached a high of $42.29, while it has fallen to a 52-week low of $24.48. The 50-Day Moving Average of the stock is -14.69%, while the 200-Day Moving Average is calculated to be -11.56%.
Shares Statistics:
The stock has traded on average 372.41K shares per day over the past 3-months and 435410 shares per day over the last 10 days, according to various share statistics. A total of 31.87M shares are outstanding, with a floating share count of 31.25M. Insiders hold about 3.11% of the company’s shares, while institutions hold 128.34% stake in the company. Shares short for COLL as of 1728950400 were 6147408 with a Short Ratio of 16.67, compared to 1726185600 on 6351017. Therefore, it implies a Short% of Shares Outstanding of 6147408 and a Short% of Float of 23.669999999999998.
